Through a retrospective analysis of multiple publicly available clinical datasets, we have shown that the transcriptional expression of P2RX4 is significantly upregulated in patient PCa samples when compared to benign prostate tissues or cells, suggesting a potential involvement of P2X4R in the development and growth of PCa malignancies. The gene discussed is P2RX4; the disease is posterior cortical atrophy.